| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Diagnostic markers for early detection of ovarian cancer.
|
Clin Cancer Res
|
2008
|
6.47
|
|
2
|
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.
|
Nat Genet
|
2009
|
5.14
|
|
3
|
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
|
Nat Genet
|
2010
|
4.89
|
|
4
|
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
|
J Natl Cancer Inst
|
2008
|
3.73
|
|
5
|
Detectable clonal mosaicism and its relationship to aging and cancer.
|
Nat Genet
|
2012
|
3.69
|
|
6
|
Physicians' weight loss counseling in two public hospital primary care clinics.
|
Acad Med
|
2004
|
2.94
|
|
7
|
Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
2.73
|
|
8
|
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
|
Cancer Res
|
2007
|
2.45
|
|
9
|
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.
|
Cancer Res
|
2008
|
2.24
|
|
10
|
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.
|
Cancer Res
|
2010
|
2.15
|
|
11
|
IGF-I and breast cancer: a meta-analysis.
|
Int J Cancer
|
2004
|
2.03
|
|
12
|
Type I and II endometrial cancers: have they different risk factors?
|
J Clin Oncol
|
2013
|
2.01
|
|
13
|
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
2.01
|
|
14
|
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
|
Breast Cancer Res Treat
|
2008
|
1.86
|
|
15
|
Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer.
|
Breast Cancer Res Treat
|
2012
|
1.60
|
|
16
|
Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis.
|
Am J Epidemiol
|
2015
|
1.58
|
|
17
|
ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
|
J Natl Cancer Inst
|
2010
|
1.54
|
|
18
|
Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.49
|
|
19
|
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
|
Endocr Relat Cancer
|
2013
|
1.47
|
|
20
|
Prevalence of overweight, obesity, and associated diseases among outpatients in a public hospital.
|
South Med J
|
2003
|
1.44
|
|
21
|
Exercise improves body fat, lean mass, and bone mass in breast cancer survivors.
|
Obesity (Silver Spring)
|
2009
|
1.41
|
|
22
|
Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II.
|
Eur J Cancer
|
2009
|
1.41
|
|
23
|
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
|
Gynecol Oncol
|
2005
|
1.40
|
|
24
|
Association between Echinococcus granulosus infection and cancer risk - a pilot study in Cyprus.
|
Clin Chem Lab Med
|
2016
|
1.39
|
|
25
|
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
|
Gynecol Oncol
|
2007
|
1.37
|
|
26
|
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.
|
PLoS One
|
2013
|
1.33
|
|
27
|
Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
|
Cancer
|
2006
|
1.24
|
|
28
|
Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials.
|
Psychooncology
|
2009
|
1.21
|
|
29
|
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer.
|
Carcinogenesis
|
2012
|
1.20
|
|
30
|
Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.
|
Cancer Res
|
2003
|
1.19
|
|
31
|
Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship Study.
|
Cancer
|
2008
|
1.16
|
|
32
|
Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
|
PLoS One
|
2013
|
1.15
|
|
33
|
ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.
|
Am J Epidemiol
|
2013
|
1.14
|
|
34
|
Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
|
Lung Cancer
|
2010
|
1.13
|
|
35
|
Adipokine genes and prostate cancer risk.
|
Int J Cancer
|
2009
|
1.10
|
|
36
|
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.
|
J Clin Oncol
|
2007
|
1.10
|
|
37
|
Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.
|
Lung Cancer
|
2007
|
1.07
|
|
38
|
Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).
|
Cancer Causes Control
|
2003
|
1.07
|
|
39
|
Testing the proportional hazards assumption in case-cohort analysis.
|
BMC Med Res Methodol
|
2013
|
1.07
|
|
40
|
Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.06
|
|
41
|
Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
|
Endocr Relat Cancer
|
2010
|
1.06
|
|
42
|
Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women.
|
Cancer Causes Control
|
2004
|
1.05
|
|
43
|
Global burden of cancer.
|
Yale J Biol Med
|
2006
|
1.05
|
|
44
|
Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
|
Ann Surg
|
2002
|
1.04
|
|
45
|
Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer.
|
Int J Cancer
|
2011
|
1.03
|
|
46
|
Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
|
Cancer Invest
|
2008
|
1.03
|
|
47
|
Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
|
Int J Surg Pathol
|
2004
|
1.02
|
|
48
|
Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.02
|
|
49
|
Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
|
Gynecol Oncol
|
2006
|
1.01
|
|
50
|
Green tea drinking and risk of pancreatic cancer: a large-scale, population-based case-control study in urban Shanghai.
|
Cancer Epidemiol
|
2012
|
1.00
|
|
51
|
A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer.
|
Ann Surg
|
2005
|
1.00
|
|
52
|
High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.
|
Ann Surg
|
2006
|
1.00
|
|
53
|
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
|
Cancer
|
2009
|
0.99
|
|
54
|
IGF-I in epithelial ovarian cancer and its role in disease progression.
|
Growth Factors
|
2007
|
0.99
|
|
55
|
Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome.
|
Breast Cancer Res
|
2011
|
0.98
|
|
56
|
Plasma metabolite biomarkers for the detection of pancreatic cancer.
|
J Proteome Res
|
2014
|
0.97
|
|
57
|
Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.96
|
|
58
|
Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls.
|
Int J Cancer
|
2011
|
0.96
|
|
59
|
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.
|
Am J Epidemiol
|
2012
|
0.95
|
|
60
|
The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
|
Clin Cancer Res
|
2006
|
0.95
|
|
61
|
Prognostic implications for high expression of MiR-25 in lung adenocarcinomas of female non-smokers.
|
Asian Pac J Cancer Prev
|
2014
|
0.94
|
|
62
|
Genome-wide association study of endometrial cancer in E2C2.
|
Hum Genet
|
2013
|
0.93
|
|
63
|
Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer.
|
Carcinogenesis
|
2012
|
0.93
|
|
64
|
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
|
Breast Cancer Res Treat
|
2009
|
0.93
|
|
65
|
Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women.
|
Int J Cancer
|
2005
|
0.92
|
|
66
|
Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).
|
J Surg Oncol
|
2012
|
0.91
|
|
67
|
Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1.
|
Breast Cancer Res Treat
|
2011
|
0.91
|
|
68
|
MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management.
|
Gynecol Oncol
|
2011
|
0.90
|
|
69
|
An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival.
|
Carcinogenesis
|
2013
|
0.90
|
|
70
|
Circulating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers.
|
PLoS One
|
2013
|
0.90
|
|
71
|
Effect of exercise on markers of inflammation in breast cancer survivors: the Yale exercise and survivorship study.
|
Cancer Prev Res (Phila)
|
2012
|
0.89
|
|
72
|
Let-7a regulation of insulin-like growth factors in breast cancer.
|
Breast Cancer Res Treat
|
2010
|
0.89
|
|
73
|
Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
|
Growth Horm IGF Res
|
2006
|
0.89
|
|
74
|
Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case-control study.
|
Eur J Nutr
|
2012
|
0.89
|
|
75
|
Insulin-like growth factor axis and oncogenic human papillomavirus natural history.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.88
|
|
76
|
Meta-Analysis of the Association between Mir-196a-2 Polymorphism and Cancer Susceptibility.
|
Cancer Biol Med
|
2012
|
0.88
|
|
77
|
Non-high-density lipoprotein cholesterol in patients with metabolic syndrome.
|
J Investig Med
|
2008
|
0.88
|
|
78
|
Helicobacter pylori seropositivities and risk of pancreatic carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.87
|
|
79
|
The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women.
|
AIDS
|
2008
|
0.87
|
|
80
|
Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma.
|
Cancer
|
2004
|
0.87
|
|
81
|
Feasibility of institutional registry-based recruitment for enrolling newly diagnosed breast cancer patients in an exercise trial.
|
J Phys Act Health
|
2011
|
0.86
|
|
82
|
Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women.
|
Breast Cancer Res Treat
|
2011
|
0.86
|
|
83
|
TLK1B is elevated with eIF4E overexpression in breast cancer.
|
J Surg Res
|
2004
|
0.85
|
|
84
|
Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women.
|
J Infect Dis
|
2008
|
0.85
|
|
85
|
Physical activity and endometrial cancer in a population-based case-control study.
|
Cancer Causes Control
|
2010
|
0.85
|
|
86
|
Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients.
|
Cancer Epidemiol
|
2009
|
0.84
|
|
87
|
Energy balance, insulin resistance biomarkers, and breast cancer risk.
|
Cancer Detect Prev
|
2007
|
0.84
|
|
88
|
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
|
Breast Cancer Res Treat
|
2008
|
0.84
|
|
89
|
Favorable outcome associated with an IGF-1 ligand signature in breast cancer.
|
Breast Cancer Res Treat
|
2012
|
0.83
|
|
90
|
Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
|
Int J Cancer
|
2014
|
0.82
|
|
91
|
Tipping the scales: the effect of literacy on obese patients' knowledge and readiness to lose weight.
|
South Med J
|
2005
|
0.81
|
|
92
|
Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.
|
Oncol Res
|
2007
|
0.81
|
|
93
|
Insulin-like growth factor-I, soy protein intake, and breast cancer risk.
|
Nutr Cancer
|
2004
|
0.81
|
|
94
|
PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer.
|
J Transl Med
|
2012
|
0.81
|
|
95
|
Polymorphisms in inflammation pathway genes and endometrial cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.81
|
|
96
|
Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
|
Surgery
|
2006
|
0.81
|
|
97
|
Ovarian preservation and staging in reproductive-age endometrial cancer patients.
|
Gynecol Oncol
|
2009
|
0.81
|
|
98
|
Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer.
|
Pancreas
|
2011
|
0.80
|
|
99
|
Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability.
|
Cancer Causes Control
|
2008
|
0.80
|
|
100
|
IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics.
|
Oncol Rep
|
2011
|
0.79
|
|
101
|
Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population.
|
Chin J Cancer
|
2013
|
0.79
|
|
102
|
Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4.
|
Cancer Causes Control
|
2013
|
0.78
|
|
103
|
Effect of exercise on metabolic syndrome variables in breast cancer survivors.
|
Int J Endocrinol
|
2013
|
0.78
|
|
104
|
Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression.
|
J Oncol
|
2011
|
0.77
|
|
105
|
DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival.
|
Cell Physiol Biochem
|
2015
|
0.77
|
|
106
|
Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis.
|
Pancreas
|
2016
|
0.76
|
|
107
|
Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer.
|
Oncol Lett
|
2013
|
0.76
|
|
108
|
Dietary energy density is positively associated with risk of pancreatic cancer in urban Shanghai Chinese.
|
J Nutr
|
2013
|
0.76
|
|
109
|
Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4).
|
Pancreas
|
2016
|
0.75
|
|
110
|
Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer".
|
Am J Epidemiol
|
2015
|
0.75
|
|
111
|
Insulin resistance-related gene polymorphisms and risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.75
|
|
112
|
Disease risk estimation by combining case-control data with aggregated information on the population at risk.
|
Biometrics
|
2014
|
0.75
|
|
113
|
Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes.
|
Cancer Causes Control
|
2011
|
0.75
|
|
114
|
Correction: vitamin d metabolic pathway genes and pancreatic cancer risk.
|
PLoS One
|
2015
|
0.75
|
|
115
|
Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium.
|
Obstet Gynecol
|
2017
|
0.75
|